The potentially valuable role of saliva biomarkers (such as NT-proBNP) in HF diagnosis and management, instead of using the serum/plasma biomarkers, is an interesting concept that has been introduced in various recent studies [3]. The gene discussed is NPPB; the disease is hydrops fetalis.